IRadimed Corporation Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	22.0M	22.7M	21.2M	20.4M	19.5M	19.4M	18.3M	17.9M
Cost of Goods Sold	5.2M	5.7M	4.7M	4.5M	4.7M	4.6M	4.1M	3.9M
Gross Profit	16.8M	17.0M	16.5M	16.0M	14.8M	14.8M	14.2M	14.0M
R&D Expenses	956K	799K	674K	877K	624K	570K	639K	801K
Operating Expenses	9.6M	9.9M	9.7M	9.2M	9.4M	9.0M	8.4M	8.4M
Operating Income	7.2M	7.1M	6.8M	6.8M	5.4M	5.8M	5.8M	5.6M
Other Income / Gains	532K	697K	464K	539K	514K	544K	629K	642K
Net Income	5.8M	6.4M	5.6M	5.8M	4.7M	5.1M	5.0M	4.9M
EPS (Diluted)	0.46	0.51	0.44	0.45	0.37	0.41	0.40	0.39
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.765	0.751	0.778	0.782	0.761	0.761	0.774	0.781
General And Administrative Expenses	4.6M	4.5M	4.4M	4.3M	4.6M	3.9M	4.0M	4.1M
Selling And Marketing Expenses	4.1M	4.6M	4.6M	4.0M	4.2M	4.5M	3.8M	3.5M
Selling General And Administrative Expenses	8.6M	9.1M	9.0M	8.3M	8.8M	8.4M	7.8M	7.6M
Other Expenses	0	0	0	0	0	0	0	0
Cost And Expenses	14.7M	15.6M	14.4M	13.6M	14.1M	13.6M	12.5M	12.3M
Interest Income	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0
Depreciation And Amortization	455K	614K	384K	592K	194K	195K	198K	199K
Ebitda	8.2M	8.4M	7.7M	7.9M	6.1M	6.5M	6.6M	6.5M
Ebitdaratio	0.374	0.37	0.362	0.388	0.315	0.337	0.361	0.361
Operating Income Ratio	0.329	0.313	0.322	0.333	0.278	0.299	0.316	0.314
Income Before Tax	7.8M	7.8M	7.3M	7.3M	5.9M	6.3M	6.4M	6.3M
Income Before Tax Ratio	0.353	0.343	0.344	0.359	0.305	0.327	0.35	0.35
Income Tax Expense	2.0M	1.3M	1.7M	1.6M	1.3M	1.2M	1.4M	1.4M
Net Income Ratio	0.265	0.284	0.263	0.283	0.24	0.265	0.276	0.273
Epsdiluted	0.45	0.50	0.43	0.45	0.37	0.40	0.40	0.38
Weighted Average Shs Out	12.8M	12.7M	12.7M	12.7M	12.7M	12.7M	12.7M	12.7M
Weighted Average Shs Out Dil	12.9M	12.9M	12.9M	12.8M	12.8M	12.8M	12.8M	12.8M